The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study

Detalhes bibliográficos
Autor(a) principal: Gorwood, Philip
Data de Publicação: 2020
Outros Autores: Benichou, Jacques, Moore, Nicholas, Álvarez Martínez, Enric, Mertens, Joost, Aguglia, Eugenio, Figueira, Maria Luísa, Falkai, Peter, Olivier, Valérie, Wattez, Marine, Picarel‐Blanchot, Françoise, de Bodinat, Christian
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/48294
Resumo: © 2020 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
id RCAP_08131f982547de3d658574cc9e5a764a
oai_identifier_str oai:repositorio.ul.pt:10451/48294
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort studyAgomelatineLiver acceptabilityObservationalSafety-medical practiceSkin events© 2020 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Objective: The present observational cohort study documented the safety of agomelatine in current medical practice in out-patients suffering from major depressive disorder. Method: The 6-month evolution of agomelatine-treated patients was assessed with a focus on safety (emergent adverse events, liver acceptability), severity of depression using the Clinical Global Impression Severity (CGI-S) score, and functioning measured by the Sheehan Disability Scale (SDS). Results: A total of 8453 depressed patients from 761 centres in 6 countries were analysed (female: 67.7%; mean age: 49.1 ± 14.8 years). Adverse events reported were in accordance with the known safety profile of agomelatine. Cutaneous events were reported in 1.7% of the patients and increased hepatic transaminases values were reported in 0.9 % of the patients. The incidence of events related to suicide/self-injury was 1.0%. Two completed suicides, not related to the study drug, were reported. CGI-S total scores and SDS sub-scores improved and numbers of days lost or underproductive decreased over the treatment period. Conclusions: In standard medical practice, agomelatine treatment was associated with a low incidence of side effects. No unexpected events were reported. A decrease in the severity of the depressive episode and improved functioning were observed.John Wiley & Sons, Inc.Repositório da Universidade de LisboaGorwood, PhilipBenichou, JacquesMoore, NicholasÁlvarez Martínez, EnricMertens, JoostAguglia, EugenioFigueira, Maria LuísaFalkai, PeterOlivier, ValérieWattez, MarinePicarel‐Blanchot, Françoisede Bodinat, Christian2021-06-01T13:56:05Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/48294engHum Psychopharmacol. 2021 Jan;36(1):1-110885-622210.1002/hup.27591099-1077info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:51:35Zoai:repositorio.ul.pt:10451/48294Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:00:11.845073Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
title The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
spellingShingle The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
Gorwood, Philip
Agomelatine
Liver acceptability
Observational
Safety-medical practice
Skin events
title_short The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
title_full The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
title_fullStr The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
title_full_unstemmed The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
title_sort The safety of agomelatine in standard medical practice in depressed patients : a 26‐week international multicentre cohort study
author Gorwood, Philip
author_facet Gorwood, Philip
Benichou, Jacques
Moore, Nicholas
Álvarez Martínez, Enric
Mertens, Joost
Aguglia, Eugenio
Figueira, Maria Luísa
Falkai, Peter
Olivier, Valérie
Wattez, Marine
Picarel‐Blanchot, Françoise
de Bodinat, Christian
author_role author
author2 Benichou, Jacques
Moore, Nicholas
Álvarez Martínez, Enric
Mertens, Joost
Aguglia, Eugenio
Figueira, Maria Luísa
Falkai, Peter
Olivier, Valérie
Wattez, Marine
Picarel‐Blanchot, Françoise
de Bodinat, Christian
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Gorwood, Philip
Benichou, Jacques
Moore, Nicholas
Álvarez Martínez, Enric
Mertens, Joost
Aguglia, Eugenio
Figueira, Maria Luísa
Falkai, Peter
Olivier, Valérie
Wattez, Marine
Picarel‐Blanchot, Françoise
de Bodinat, Christian
dc.subject.por.fl_str_mv Agomelatine
Liver acceptability
Observational
Safety-medical practice
Skin events
topic Agomelatine
Liver acceptability
Observational
Safety-medical practice
Skin events
description © 2020 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
2021-06-01T13:56:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/48294
url http://hdl.handle.net/10451/48294
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Hum Psychopharmacol. 2021 Jan;36(1):1-11
0885-6222
10.1002/hup.2759
1099-1077
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv John Wiley & Sons, Inc.
publisher.none.fl_str_mv John Wiley & Sons, Inc.
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134548873707520